Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation form
Neurological Sciences · 2025-09 · 46 (9) · 4633-4643
DOI: 10.1007/s10072-025-08276-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, online erschienen am 13.06.2025. Verfasst von Giulia Ricci und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. giulia.ricci@unipi.it. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Phenotype. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
BACKGROUND: Facioscapolohumeral muscular dystrophy is characterized by a wide clinical variability; the underlying reasons and the relation between them and the genetic markers are still not clear. In fact, the different phenotypes could show a different disease progression and/or imply distinct genetic mechanisms. As clinical trials are approaching also for FSHD, the correct description and stratification of patients becomes mandatory. To address these matters, in 2016 the Italian Clinical Group for FSHD developed the Comprehensive Clinical Evaluation Form (CCEF), aimed at describing the different observed phenotypes in FSHD. METHODS: A working group composed by the former developers of the CCEF and other expert clinicians re-evaluated the whole structure of the CCEF, to develop a simplified version for use in clinical practice; also, other expert clinicians not referring to the Italian Clinical Group for FSHD read and approved the CCEF revised version for its international use. RESULTS: We present the CCEF-R, a revised and simplified version of the CCEF, that while maintaining all the core structure and items of the previous validated version, has been modified with new friendlier graphics, focused on the key anamnestic and neurological examination findings, to facilitate its understanding and use in clinical practice. CONCLUSIONS: The phenotypical classification combined with the genetic signature should be considered during the diagnostic work out for guiding genetic analysis and for genotype-phenotype correlations and genetic counseling. The CCEF could have a significant role in the clinical stratification process of patients for clinical trials and in laying the groundwork for evidence-based medical decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. giulia.ricci@unipi.it.
- Department of Translational Research and New Technologies in Medicine and Surgery, Univeristy of Pisa, Pisa, Italy.
- Department of Neuroscience, Reproductive and Odontostomatological Science, University of Naples "Federico II", Naples, Italy.
- Department of Neuroscience RLM, Neuromuscular Unit, University of Torino, Turin, Italy.
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
- NeMO-Brescia Clinical Center for Neuromuscular Diseases, Brescia, Italy.
Förderung
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Ricci, G., Torri, F., Ruggiero, L., Vercelli, L., Gadaleta, G., Rolle, E., Risi, B., Carraro, E., Evangelista, T., Bugiardini, E., Dubuisson, N., Voermans, N., Siciliano, G., Mongini, T., Filosto, M., & Italian Clinical Network for FSHD (2025). Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation form. Neurological Sciences, 46(9), 4633-4643. https://doi.org/10.1007/s10072-025-08276-7
Vancouver
Ricci G, Torri F, Ruggiero L, Vercelli L, Gadaleta G, Rolle E, et al. Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation form. Neurological Sciences. 2025;46(9):4633-4643. doi:10.1007/s10072-025-08276-7
BibTeX
@article{Ricci2025,
author = {Ricci, Giulia and Torri, Francesca and Ruggiero, Lucia and Vercelli, Liliana and Gadaleta, Giulio and Rolle, Enrica and Risi, Barbara and Carraro, Elena and Evangelista, Teresinha and Bugiardini, Enrico and Dubuisson, Nicolas and Voermans, Nicol and Siciliano, Gabriele and Mongini, Tiziana and Filosto, Massimiliano and Italian Clinical Network for FSHD, Italian Clinical Network for FSHD},
title = {Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation form},
journal = {Neurological Sciences},
year = {2025},
volume = {46},
number = {9},
pages = {4633--4643},
doi = {10.1007/s10072-025-08276-7}
}
EUVIMED